Coffee Drops Risk for Atrial Fibrillation, Flutter - Medscape
The DECAF trial shows that drinking one cup of caffeinated coffee a day may actually reduce atrial fibrillation or flutter.
Atrial Fibrillation Early Recurrence After Cardioversion - Medscape
Atrial fibrillation recurrence is common, especially during the first 2 weeks, even when the patients are on antiarrhythmic therapy . . .
ED Cardioversion Safe in Patients With Severe Obesity - Medscape
Sep 15, 2025 · ED cardioversion restores rhythm in patients with class III-IV obesity and atrial fibrillation or flutter, achieving a 92.3% success rate without any airway events, a study finds.
A Coffee a Day to Keep the AFib Away? - Medscape
Michelle O’Donoghue and Gregory Marcus review the clinical implications of the DECAF randomized trial of caffeinated coffee or avoiding caffeine after successful cardioversion for …
Electrical Cardioversion for AF -- The State of the Art
Aside from patient factors, a number of factors may influence the immediate success of cardioversion, that is, a complete failure to cardiovert. These include electrode placement, …
Metoprolol for preventing relapse in AF? - Medscape
Jul 12, 2000 · Metoprolol was superior to placebo for preventing relapse into AF or flutter after cardioversion to sinus rhythm, the German group concludes. The reported effects cannot be …
Optimal Pad Position in Transcutaneous Pacing - Medscape
Jan 11, 2023 · After successful cardioversion to sinus rhythm, the cardioversion pads were removed, and two new sets of pacer pads were placed on the patients' chests.
Adenosine Safe for Pediatric Tachyarrhythmia - Medscape
Sep 17, 2024 · A study found adenosine to be safe as a first-line treatment for pediatric supraventricular tachycardia, with no serious side effects observed during a decade of use.
To Cease or Not to Cease Anticoagulation After AF Ablation
May 25, 2023 · The study also found a significantly reduced risk for stroke and TIA in the ablation group compared with the cardioversion group after the initial 30-day post-procedure period.
FDA Approves First Pulsed Field Ablation System for AF - Medscape
Medtronic's PulseSelect Pulsed Field Ablation System was approved for the treatment of paroxysmal and persistent atrial fibrillation.